As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

United States next-generation biomanufacturing market is anticipated to witness significant growth during the forecast period owing to thriving biopharmaceutical sector and increasing funds being provided by government for the development of innovative biomanufacturing technologies. The addition of new products in the development pipeline and entry of more companies in next-generation biomanufacturing are further acting as key growth factors for United States next-generation biomanufacturing market. Additionally, the market is focusing on the implementation of single-use products including single-use bio-containers and single-use bioreactors, which is further fueling the market. Also, the advantages of next-generation biomanufacturing such as adoption of cost savings facilities and reduced risk of contamination of products is expected to further drive the market growth through 2025.

Moreover, the outbreak of COVID-19 has pushed biomanufacturing industries to develop vaccines, hence, with development of advanced vaccines, next-generation biomanufacturing market is expected to grow significantly in United States. In addition to this, growing awareness regarding the benefits next-generation biomanufacturing and presence of leading manufacturers is making United States a favorable market for next-generation biomanufacturing.

United States next-generation biomanufacturing market is categorized based on type, medical application, end users and region. Based on application, the market can be segmented into monoclonal antibodies, hormones, vaccines, recombinant proteins and others. Among them, the monoclonal antibodies segment is anticipated to witness high growth through 2025 due to high rate of products approval and occurrence of coronavirus which has led to extensive development of vaccines.

Based on end users, the United States next-generation biomanufacturing market can be segmented into biopharmaceutical companies, CMOs/CDMOs and research institutions. Among them, biopharmaceutical companies are expected to contribute to major share of revenue the United States next-generation biomanufacturing market during the forecast period owing to higher number of biopharmaceutical companies and increasing adoption of advanced healthcare technologies.

Major players operating in the United States next-generation biomanufacturing market include Thermo Fisher Scientific, Inc., Danaher Corporation, Merck & Co., Inc., Eppendorf, Inc., Sartorius Corporation, GEA North America, Inc., PBS Biotech, Inc, Applikon Biotechnology, Inc. and Meissner Filtration Products, Inc., among others. The market players are undergoing growth strategies like strategic partnerships and strategic collaborations & partnerships.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of United States next-generation biomanufacturing market from 2015 to 2018.
  • To estimate and forecast the market size of United States next-generation biomanufacturing market from 2019 to 2025 and growth rate until 2025.
  • to classify and forecast United States next-generation biomanufacturing market based on type, medical application, end users, company and regional distribution.
  • To identify dominant region or segment in the United States next-generation biomanufacturing market.
  • To identify drivers and challenges for United States next-generation biomanufacturing market.
  • To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States next-generation biomanufacturing market.
  • To conduct pricing analysis for United States next-generation biomanufacturing market.
  • To identify and analyze the profile of leading players operating in United States next-generation biomanufacturing market.
  • To identify key sustainable strategies adopted by market players in United States next-generation biomanufacturing market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of next-generation biomanufacturing companies across United States. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies who could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the countries.

TechSci Research calculated the market size of United States next-generation biomanufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and end users for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Next-generation biomanufacturing manufactures, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to next-generation biomanufacturing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as next-generation biomanufacturing manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States next-generation biomanufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United States Next-Generation Biomanufacturing Market, By Type:
    • Continuous Upstream Biomanufacturing
    • Single-Use Upstream Biomanufacturing
    • Downstream Biomanufacturing
  • United States Next-Generation Biomanufacturing Market, By Medical Application:
    • Monoclonal Antibodies
    • Hormones
    • Vaccines
    • Recombinant Proteins
    • Others
  • United States Next-Generation Biomanufacturing Market, By End Users:
    • Biopharmaceutical Companies
    • CMOs/CDMOs
    • Research Institutions
  • United States Next-Generation Biomanufacturing Market, By Region:
    • North-East
    • Mid-West
    • West
    • South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States next-generation biomanufacturing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Next-Generation Biomanufacturing Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Next Generation Biomanufacturing Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Type (Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing)

6.2.2.     By Medical Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Others)

6.2.3.     By End Users (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutions)

6.2.4.     By Region

6.2.5.     By Company

6.3.  Product Market Map

7.    United States Continuous Upstream Biomanufacturing Market Outlook

7.1.  Market Size & Forecast

7.1.1. By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Medical Application

7.2.2.     By End Users

8.    United States Single-Use Upstream Biomanufacturing Market Outlook

8.1.  Market Size & Forecast

8.1.1. By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Medical Application

8.2.2.     By End Users

9.    United States Downstream Biomanufacturing Market Outlook

9.1.  Market Size & Forecast

9.1.1. By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Medical Application

9.2.2.     By End Users

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Development

12.  Policy & Regulatory Landscape

13.  Import Export Analysis

14.  United States Economic Profile

15.  Competitive Landscape

15.1.              Competition Outlook

15.2.              Company Profiles

15.2.1.  Thermo Fisher Scientific, Inc.

15.2.2.  Danaher Corporation

15.2.3.  Merck & Co., Inc.

15.2.4.  Eppendorf, Inc.

15.2.5.  Sartorius Corporation

15.2.6.  GEA North America, Inc.

15.2.7.  PBS Biotech, Inc

15.2.8.  Applikon Biotechnology, Inc.

15.2.9.  Meissner Filtration Products, Inc.

16.  Strategic Recommendations

17.  About Us & Disclaimer

 (Note: The companies list can be customized based on the client requirements.)

 

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com